Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Colon Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of antineoplaston therapy for Stage IV colon cancer and recurrent colon cancer conducted by the Burzynski Research Institute has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Colon Cancer

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Stage IV Colon Cancer, Recurrent Colon Cancer | Phase 2 | Status: WITHDRAWN